Pharmaceutical Information |
Drug Name |
Lormetazepam |
Drug ID |
BADD_D01321 |
Description |
Lormatazepam is an orally available benzodiazepine used in the UK for the treatment of short-term insomnia [L927]. It is marketed by Auden Mckenzie (Pharma Division) in 0.5 and 1 mg tablet formulations. |
Indications and Usage |
For the treatment of short-term insomnia [L927] |
Marketing Status |
Not Available |
ATC Code |
N05CD06 |
DrugBank ID |
DB13872
|
KEGG ID |
D01657
|
MeSH ID |
C023842
|
PubChem ID |
13314
|
TTD Drug ID |
D0I8HJ
|
NDC Product Code |
12828-0021 |
Synonyms |
lormetazepam | methyllorazepam |
|
Chemical Information |
Molecular Formula |
C16H12Cl2N2O2 |
CAS Registry Number |
848-75-9 |
SMILES |
CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3Cl |
Chemical Structure |
|
|
ADR Related Proteins Induced by Drug |
ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
Not Available | Not Available | Not Available | Not Available | Not Available |
|
ADRs Induced by Drug |
|